AIM
EPZM

Aigen Investment Management’s Epizyme, Inc EPZM Stock Holding History

Aigen Investment Management’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-14,566
Closed -$158K – 963
2020
Q4 		$158K Sell
14,566
-102,864
-88% -$1.27M 0.02% 705
2020
Q3 		$1.4M Buy
+117,430
New +$1.57M 0.18% 175
2020
Q2 		– Sell
-1,422
Closed -$22K – 1409
2020
Q1 		$22K Sell
1,422
-19,358
-93% -$416K ﹤0.01% 1088
2019
Q4 		$511K Buy
+20,780
New +$308K 0.08% 308

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return